X-101625760-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_177947.3(ARMCX3):c.781C>T(p.Leu261Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000937 in 1,066,671 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_177947.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARMCX3 | NM_177947.3 | c.781C>T | p.Leu261Phe | missense_variant | 5/5 | ENST00000471229.7 | NP_808816.1 | |
ARMCX3 | NM_016607.4 | c.781C>T | p.Leu261Phe | missense_variant | 5/5 | NP_057691.1 | ||
ARMCX3 | NM_177948.3 | c.781C>T | p.Leu261Phe | missense_variant | 5/5 | NP_808817.1 | ||
ARMCX3 | XM_005262141.4 | c.781C>T | p.Leu261Phe | missense_variant | 5/5 | XP_005262198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARMCX3 | ENST00000471229.7 | c.781C>T | p.Leu261Phe | missense_variant | 5/5 | 1 | NM_177947.3 | ENSP00000454483 | P1 | |
ARMCX3 | ENST00000341189.8 | c.781C>T | p.Leu261Phe | missense_variant | 5/5 | 1 | ENSP00000340672 | P1 | ||
ARMCX3 | ENST00000537169.1 | c.781C>T | p.Leu261Phe | missense_variant | 5/5 | 1 | ENSP00000439032 | P1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome AF: 9.37e-7 AC: 1AN: 1066671Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 346595
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.